A
Alison Pritchard
Researcher at Wellington Management Company
Publications - 17
Citations - 1242
Alison Pritchard is an academic researcher from Wellington Management Company. The author has contributed to research in topics: Asthma & Formoterol. The author has an hindex of 14, co-authored 16 publications receiving 1087 citations.
Papers
More filters
Journal ArticleDOI
Effects of cannabis on pulmonary structure, function and symptoms
Sarah Aldington,Mathew Williams,Michael Nowitz,Mark Weatherall,Alison Pritchard,Amanda McNaughton,Geoffrey Robinson,Richard Beasley +7 more
TL;DR: Smoking cannabis was associated with a dose-related impairment of large airways function resulting in airflow obstruction and hyperinflation and the 1:2.5–5 dose equivalence between cannabis joints and tobacco cigarettes for adverse effects on lung function is of major public health significance.
Journal ArticleDOI
Reference Ranges for Exhaled Nitric Oxide Derived from a Random Community Survey of Adults
Justin Travers,Suzanne Marsh,Sarah Aldington,Mathew Williams,Philippa Shirtcliffe,Alison Pritchard,Mark Weatherall,Richard Beasley +7 more
TL;DR: Measurement of Fe(NO) had poor discriminant ability to identify steroid-naive subjects with asthma and several reference ranges are presented adjusting for these factors.
Journal ArticleDOI
Cannabis use and risk of lung cancer: a case–control study
Sarah Aldington,Matire Harwood,Brian Cox,Mark Weatherall,Lutz Beckert,Anna Hansell,Alison Pritchard,Geoffrey Robinson,Richard Beasley +8 more
TL;DR: The results of the present study indicate that long-term cannabis use increases the risk of lung cancer in young adults.
Journal ArticleDOI
Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial
Mitesh Patel,Mitesh Patel,Janine Pilcher,Alison Pritchard,Kyle Perrin,Justin Travers,Dominick E. Shaw,Shaun Holt,Shaun Holt,Matire Harwood,Peter N. Black,Mark Weatherall,Mark Weatherall,Richard Beasley +13 more
TL;DR: This trial investigated whether the SMART regimen would reduce the risk of overuse of β agonist, reduce the likelihood of patients to seek medical review when such episodes occurred, and if any reduction in severe asthma exacerbations would be at the cost of a higher burden of systemic corticosteroid.
Journal ArticleDOI
Accuracy of patient self-report as a measure of inhaled asthma medication use
Mitesh Patel,Kyle Perrin,Alison Pritchard,Mathew Williams,Meme Wijesinghe,Mark Weatherall,Mark Weatherall,Richard Beasley,Richard Beasley +8 more
TL;DR: The aim of this study was to determine the relationship between self‐report and actual medication use as measured by electronic monitoring for single and combination inhaled corticosteroid and long‐acting beta‐agonist metered‐dose inhaler therapy.